Cited by 43Smoking Behavior and CessationGenetic Associations and EpidemiologyNicotinic Acetylcholine Receptors Study

Rare, low frequency and common coding variants in CHRNA5 and their contribution to nicotine dependence in European and African Americans

Open access
Olfson, E, Saccone, N L, Johnson, E O, Chen, L-S, Culverhouse, R, Doheny, K, Foltz, S M, Fox, L +45 more·2016·Molecular Psychiatry

Abstract

The common nonsynonymous variant rs16969968 in the α5 nicotinic receptor subunit gene (CHRNA5) is the strongest genetic risk factor for nicotine dependence in European Americans and contributes to risk in African Americans. To comprehensively examine whether other CHRNA5 coding variation influences nicotine dependence risk, we performed targeted sequencing on 1582 nicotine-dependent cases (Fagerström Test for Nicotine Dependence score⩾4) and 1238 non-dependent controls, with independent replication of common and low frequency variants using 12 studies with exome chip data. Nicotine dependence was examined using logistic regression with individual common variants (minor allele frequency (MAF)⩾0.05), aggregate low frequency variants (0.05>MAF⩾0.005) and aggregate rare variants (MAF<0.005). Meta-analysis of primary results was performed with replication studies containing 12 174 heavy and 11 290 light smokers. Next-generation sequencing with 180 × coverage identified 24 nonsynonymous variants and 2 frameshift deletions in CHRNA5, including 9 novel variants in the 2820 subjects. Meta-analysis confirmed the risk effect of the only common variant (rs16969968, European ancestry: odds ratio (OR)=1.3, P=3.5 × 10(-11); African ancestry: OR=1.3, P=0.01) and demonstrated that three low frequency variants contributed an independent risk (aggregate term, European ancestry: OR=1.3, P=0.005; African ancestry: OR=1.4, P=0.0006). The remaining 22 rare coding variants were associated with increased risk of nicotine dependence in the European American primary sample (OR=12.9, P=0.01) and in the same risk direction in African Americans (OR=1.5, P=0.37). Our results indicate that common, low frequency and rare CHRNA5 coding variants are independently associated with nicotine dependence risk. These newly identified variants likely influence the risk for smoking-related diseases such as lung cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mp.2015.105

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • GWAS implicated α4 and α5 nicotinic receptor subunits in vulnerability to nicotine dependence and a SNP regulating trafficking and gating of AMPA-selective glutamate receptors (CNIH3) in opioid dependence.

    “For example, genome-wide association studies have implicated two acetylcholine receptors, the α4 nicotinic receptor subunit157 and α5 nicotinic receptor subunit,158 in the vulnerability to nicotine dependence and a single-nucleotide polymorphism associated with regulating the trafficking and gating properties of AMPA-selective glutamate receptors (CNIH3) in opioid dependence.159”

    From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [158]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Olfson, E., Saccone, N. L., Johnson, E. O., Chen, L.-S., Culverhouse, R., Doheny, K., Foltz, S. M., Fox, L., Gogarten, S. M., Hartz, S., Hetrick, K., Laurie, C. C., Marosy, B., Amin, N., Arnett, D., Barr, R. G., Bartz, T. M., Bertelsen, S., Borecki, I. B., Brown, M. R., Chasman, D. I., van Duijn, C. M., Feitosa, M. F., Fox, E. R., Franceschini, N., Franco, O. H., Grove, M. L., Guo, X., Hofman, A., Kardia, S. L. R., Morrison, A. C., Musani, S. K., Psaty, B. M., Rao, D. C., Reiner, A. P., Rice, K., Ridker, P. M., Rose, L. M., Schick, U. M., Schwander, K., Uitterlinden, A. G., Vojinovic, D., Wang, J.-C., Ware, E. B., Wilson, G., Yao, J., Zhao, W., Breslau, N., Hatsukami, D., Stitzel, J. A., Rice, J., Goate, A., & Bierut, L. J.
Affiliations
  • Washington University in St. Louis (US)
  • RTI International (US)
  • Johns Hopkins University (US)
  • University of Washington (US)
  • Erasmus MC (NL)
  • University of Alabama at Birmingham (US)
  • Columbia University Irving Medical Center (US)
  • Icahn School of Medicine at Mount Sinai (US)
  • The University of Texas Health Science Center at Houston (US)
  • Brigham and Women's Hospital (US)
  • University of Mississippi Medical Center (US)
  • University of North Carolina at Chapel Hill (US)
  • Harbor–UCLA Medical Center (US)
  • University of Michigan (US)
  • Kaiser Permanente Washington Health Research Institute (US)
  • Fred Hutch Cancer Center (US)
  • Jackson State University (US)
  • Michigan State University (US)
  • University of Minnesota (US)
  • University of Colorado Boulder (US)
Corresponding author
Bierut, L J
Venue
Molecular Psychiatry
Published
2015-08-04
Volume
21
Issue
5
Pages
601-607
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W1066198400
Cited by
43
References
38
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 1 · 2020: 4 · 2019: 2 · 2018: 9 · 2017: 5 · 2016: 8 · 2015: 1
FWCI
5.65
Type
journal article
Language
en
Open access
Locations
  • Molecular Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • PubMed Central (acceptedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • RePub (Erasmus University Rotterdam) (submittedVersion)
Funders
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (047.017.043)
  • Nestec
  • National Institutes of Health (n01hc95164-17-0-1, n01hc085082-026, n01hc085081-021, n01hc085079-024, 1r01hl120393-01a1, n01hc085083-027, n01hc95165-34-0-1, n01hc085080-026, n01hc95161-24-0-1, n01hc095169-003, UL1TR000124, HHSN268201100004C, n01hc95166-21-0-1, n01hc085086-022, n01hc95162-31-0-1, n01hc95168-27-0-1, n01hc95160-18-0-1, n01hc095167-000, HHSN268201100001C, HHSN268201100002C, 5u01hl054472-10, n01hc95163-22-0-1, 1rc2hl103010-01, n01hc55222-0-0-0, n02hl64278-6-0-0, 5r01hl043851-10, UL1TR000448, n01hc95159-40-0-1, TL1TR000449, UL1TR000040, HHSN268201100003C)
  • National Institute on Alcohol Abuse and Alcoholism (F30AA023685, U10AA008401)
  • National Institute on Aging (HHSN-271-2011-00004C,, R01AG055406, R01AG023629)
  • National Heart, Lung, and Blood Institute (R01HL071917, HHSN268201 100012C, R01HL080467, HHSN268201300050C, HHSN268201100007I, R01HL071205, U10HL054497, N01 HC085086, HHSN268201100007C, HL-54509, HHSN268201300046C, HL 54497, N01-HC095169, R21HL123677, HL-054481, HHSN2682 01100008C, N01-HC-095165, HH-SN-268201100006C, R01HL071252, HL-54471, HHSN268201100011C, HL 54496, HL 54472, U10HL054464, HHSN2682011-00005I, HL54495, R01HL085251, HL-54515, U01-HL054472, N01 HC085079, N01 HC095163, HHSN2682011-00001I, R01‐HL043851, R01-HL120393, N01 HC085083, HHSN2682011-00002I, R01HL071259, HL-54473, HL-054457, HHSN2682011-­00009I, R01 HL-59367, U10HL054509, U01HL054495, U01HL054497, N01 HC085080, R01HL087652, HHSN268201100005C, R01HL103612, R01HL068986, HHSN 268200800007C, R01HL071251, N02 HL064278, HL054464, HHSN268201300048C, HHSN268201100005G, R01HL087660, HHSN268201100010C, U10HL054473, U01HL054496, U10HL054471, RC2HL-103010, R01HL118305, N01-HC-095159, U01HL54473, N01 HC095168, N01-HC-095162, U01HL054471, R01HL119443, HHSN2682011‐00004I, N01-HC-095161, HHSN268201100011I, HHSN268201300049C, HL 103010, HL071917, HL118305, R01HL071051, R01HL071250, UC2HL103010, R01HL087641, HHSN268201200036C, R01HL059367, HHSN268201100046C, R01-HL55673, U10HL054457, U10HL054495, HHSN26820 1100009C, N01 HC095167, N01HC085082, HL119443, R01HL105756, U01HL080295, HL080467, N01-HC-095160, N01 HC055222, N01 HC095166, U01HL054457, N01 HC095164, U01HL054509, HHSN2682011-00008I, HHSN2682011-00003I, U10HL054481, N01 HC085081, HHSN268201300047C, R01HL071258, U01HL054473, U01HL054464, U10HL054515, R01HL117078, U10HL054472, R01HL055673, RC2HL102419, U01HL054481, R01HL077612, R01HL086694, U10HL054496, HL-87660)
  • National Institute on Drug Abuse (K08DA032680, K08DA030398, R01DA026911, R01DA038076, R01DA025888)
  • National Cancer Institute (P01CA089392, U19CA148127, CA 047988, UM1CA182913, P01 CA89392, R01CA047988, U19CA148172)
  • National Institute of General Medical Sciences (T32 GM-07200, T32GM007200)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK063491, R01DK089256, P30DK063491)
  • National Institute of Neurological Disorders and Stroke (R01NS041558, NS041558)
  • National Center for Research Resources (UL1RR025005)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
Keywords
CHRNA5, nicotine dependence, nicotinic acetylcholine receptors, rs16969968, non-synonymous mutations, low-frequency variants, rare variants, African Americans, European Americans, genetic risk factors, smoking, lung cancer risk, frameshift deletion
MeSH terms
Adult, Black or African American, Female, Humans, Male, Middle Aged, Nerve Tissue Proteins, Receptors, Nicotinic, Tobacco Use Disorder, Genetic Variation, Genetic Predisposition to Disease, White People

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review